We are live on ! Find out more
IQMD

Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD

Delisted

IQMD was delisted on the 26th of April, 2023.

Back to rankings

0 hedge funds and large institutions have $0 invested in Intelligent Medicine Acquisition Corp. Class A Common Stock in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

6.99% less ownership

Funds ownership: 6.99% → 0% (-7%)

100% less funds holding

Funds holding: 8 → 0 (-8)

100% less capital invested

Capital invested by funds: $5.26M → $0 (-$5.26M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 8

Holders
–
Holders Change
-8
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$2.06M
2
Walleye Capital
Walleye Capital
New York
-$1.15M
3
CF
Cantor Fitzgerald
New York
-$1.03M
4
Walleye Trading
Walleye Trading
New York
-$647K
5
WAM
Wolverine Asset Management
Illinois
-$190K

IQMD Hedge Fund Activity: Q2 2023 in Review

0 of the 6,384 institutional investors tracked by Wall St. Rank reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) for Q2 2023, worth a combined $0 — down 100% from $5.26M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of IQMD and 0 opened new positions — a net loss of 8 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Goldman Sachs, exiting entirely with an estimated $2.06M sold.

  • 0 institutional investors held Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) as of Q2 2023, down from 8 in Q1 2023.
  • Funds reported $0 of Intelligent Medicine Acquisition Corp. Class A Common Stock stock for Q2 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Intelligent Medicine Acquisition Corp. Class A Common Stock positions in Q2 2023 and 8 closed out, a net change of -8 holders.
  • The largest Intelligent Medicine Acquisition Corp. Class A Common Stock seller in Q2 2023 was Goldman Sachs, an estimated $2.06M sold.

Based on aggregated 13F filings for Q2 2023.